432 related articles for article (PubMed ID: 31188898)
1. Podocin and uPAR are good biomarkers in cases of Focal and segmental glomerulosclerosis in pediatric renal biopsies.
Pereira LHM; da Silva CA; Monteiro MLGDR; Araújo LS; Rocha LP; Reis MBDR; Ramalho FS; Corrêa RRM; Silva MV; Reis MA; Machado JR
PLoS One; 2019; 14(6):e0217569. PubMed ID: 31188898
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Diagnostic Potential of uPAR as a Biomarker in Renal Biopsies of Patients with FSGS.
da Silva CA; Araújo LS; Dos Reis Monteiro MLG; de Morais Pereira LH; da Silva MV; Castellano LRC; Corrêa RRM; Dos Reis MA; Machado JR
Dis Markers; 2019; 2019():1070495. PubMed ID: 31191741
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Glomerular Transcriptome Profiles of Adult-Onset Steroid Sensitive Focal Segmental Glomerulosclerosis and Minimal Change Disease.
Tong J; Xie J; Ren H; Liu J; Zhang W; Wei C; Xu J; Zhang W; Li X; Wang W; Lv D; He JC; Chen N
PLoS One; 2015; 10(11):e0140453. PubMed ID: 26536600
[TBL] [Abstract][Full Text] [Related]
4. Reduced podocin expression in minimal change disease and focal segmental glomerulosclerosis is related to the level of proteinuria.
Agrawal V; Prasad N; Jain M; Pandey R
Clin Exp Nephrol; 2013 Dec; 17(6):811-8. PubMed ID: 23377573
[TBL] [Abstract][Full Text] [Related]
5. In situ evaluation of podocytes in patients with focal segmental glomerulosclerosis and minimal change disease.
da Silva CA; Monteiro MLGDR; Araújo LS; Urzedo MG; Rocha LB; Dos Reis MA; Machado JR
PLoS One; 2020; 15(11):e0241745. PubMed ID: 33147279
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of C4d expression and staining patterns by immunohistochemistry in renal biopsy samples with focal segmental glomerulosclerosis and minimal change disease.
Abedi M; Nili F; Dehkhoda F; Abdollahi A; Salarvand S
Ann Diagn Pathol; 2024 Jun; 70():152281. PubMed ID: 38417352
[TBL] [Abstract][Full Text] [Related]
7. Indications for kidney biopsy in idiopathic childhood nephrotic syndrome.
Alshami A; Roshan A; Catapang M; Jöbsis JJ; Kwok T; Polderman N; Sibley J; Sibley M; Mammen C; Matsell DG;
Pediatr Nephrol; 2017 Oct; 32(10):1897-1905. PubMed ID: 28540445
[TBL] [Abstract][Full Text] [Related]
8. Reduced INF2 expression in nephrotic syndrome is possibly related to clinical severity of steroid resistance in children.
Tamura H; Nakazato H; Kuraoka S; Yoneda K; Takahashi W; Endo F
Nephrology (Carlton); 2016 Jun; 21(6):467-75. PubMed ID: 26383224
[TBL] [Abstract][Full Text] [Related]
9. [Minimal change disease and focal segmental glomerulosclerosis in children--histomorphometric comparative study with application to computer image analysis].
Danilewicz M; Wagrowska-Danilewicz M
Przegl Lek; 1996; 53(7):529-33. PubMed ID: 8975287
[TBL] [Abstract][Full Text] [Related]
10. Glomerular malondialdehyde levels in patients with focal and segmental glomerulosclerosis and minimal change disease.
Nezhad ST; Momeni B; Basiratnia M
Saudi J Kidney Dis Transpl; 2010 Sep; 21(5):886-91. PubMed ID: 20814126
[TBL] [Abstract][Full Text] [Related]
11. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V; López D; Boixadera E; Ibernón M; Espinal A; Bonet J; Romero R
BMC Nephrol; 2017 Feb; 18(1):49. PubMed ID: 28158993
[TBL] [Abstract][Full Text] [Related]
12. Expression of DENDRIN in several glomerular diseases and correlation to pathological parameters and renal failure - preliminary study.
Mizdrak M; Vukojević K; Filipović N; Čapkun V; Benzon B; Durdov MG
Diagn Pathol; 2018 Nov; 13(1):90. PubMed ID: 30458823
[TBL] [Abstract][Full Text] [Related]
13. [Structure and function of the glomerular filtration barrier].
Musiał K; Zwolińska D
Pol Merkur Lekarski; 2005 Mar; 18(105):317-20. PubMed ID: 15997642
[TBL] [Abstract][Full Text] [Related]
14. Urinary peptide profiling to differentiate between minimal change disease and focal segmental glomerulosclerosis.
Pérez V; Ibernón M; López D; Pastor MC; Navarro M; Navarro-Muñoz M; Bonet J; Romero R
PLoS One; 2014; 9(1):e87731. PubMed ID: 24498182
[TBL] [Abstract][Full Text] [Related]
15. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance.
Cara-Fuentes G; Wei C; Segarra A; Ishimoto T; Rivard C; Johnson RJ; Reiser J; Garin EH
Pediatr Nephrol; 2014 Aug; 29(8):1363-71. PubMed ID: 24263531
[TBL] [Abstract][Full Text] [Related]
16. Analysis of glomerular deposition of IgM and C3 in patients with podocytopathies.
Aparecida Ferreira V; Aparecida da Silva C; Rodrigues do Carmo Neto J; Rocha LP; Monteiro Dos Santos Martins AL; Antônia Dos Reis M; Machado JR
Ann Diagn Pathol; 2024 Jun; 70():152292. PubMed ID: 38484478
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin G/albumin staining in tubular protein reabsorption droplets in minimal change disease and focal segmental glomerulosclerosis.
Bu L; Mirocha J; Haas M
Nephrol Dial Transplant; 2021 May; 36(6):1016-1022. PubMed ID: 32191308
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of fibroblast-specific protein-1 expression on podocytes in patients with focal segmental glomerulosclerosis.
Samejima K; Nakatani K; Suzuki D; Asai O; Sakan H; Yoshimoto S; Yamaguchi Y; Matsui M; Akai Y; Toyoda M; Iwano M; Saito Y
Nephron Clin Pract; 2012; 120(1):c1-7. PubMed ID: 22126861
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases.
Schmid H; Henger A; Cohen CD; Frach K; Gröne HJ; Schlöndorff D; Kretzler M
J Am Soc Nephrol; 2003 Nov; 14(11):2958-66. PubMed ID: 14569107
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD40 ligand directly alters glomerular permeability and may act as a circulating permeability factor in FSGS.
Doublier S; Zennaro C; Musante L; Spatola T; Candiano G; Bruschi M; Besso L; Cedrino M; Carraro M; Ghiggeri GM; Camussi G; Lupia E
PLoS One; 2017; 12(11):e0188045. PubMed ID: 29155846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]